28 February 2017
News and Views
Links and Services
This week's issue of the New England Journal of Medicine compares multitarget stool DNA testing with fecal immunochemical tests for colorectal cancer screening.
An accurate, noninvasive test could improve the effectiveness of colorectal-cancer screening.
Email this page to a colleague
GastroHep.com is a Blackwell Publishing registered trademark
© 2017 Wiley-Blackwell and GastroHep.com and contributors